KPCB XV ASSOCIATES, LLC Holdings
KPCB XV ASSOCIATES, LLC is an investment fund managing more than 35.84M US dollars. The largest holdings include RAPT Therapeutics, Twilio and Atara Biotherapeutics. In Q2 2021 the fund bought assets of total value of 10.56M US dollars and sold assets of total value of 20.9M US dollars.
KPCB XV ASSOCIATES, LLC portfolio value:
KPCB XV ASSOCIATES, LLC quarter portfolio value change:
KPCB XV ASSOCIATES, LLC 1 year portfolio value change:
KPCB XV ASSOCIATES, LLC portfolio changes
Period | Buy | Sel |
---|---|---|
Q2 2021 | 10556000 | 20895000 |
KPCB XV ASSOCIATES, LLC 13F holdings
Stock |
---|
Portfolio share: 43.54% Portfolio value: 15.60M Avg. open price: N/A Current price: $17.6 P/L: N/A Sold -50.00% shares Q3 2022 |
Portfolio share: 36.66% Portfolio value: 13.14M Avg. open price: $298.66 Current price: $48.64 P/L: -83.71% Bought +1.00% shares Q1 2022 |
Portfolio share: 19.79% Portfolio value: 7.09M Avg. open price: N/A Current price: $4.76 P/L: N/A N/A Q4 2020 |
Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.14 P/L: N/A Sold -100.00% shares Q3 2022 |
Showing TOP 4 KPCB XV ASSOCIATES's 13F holdings.
Frequently Asked Questions (FAQ)
What is the biggest position of KPCB XV ASSOCIATES, LLC?
The biggest position of the KPCB XV ASSOCIATES, LLC is RAPT Therapeutics, Inc. (RAPT) with 43.54% portfolio share worth of 15.6M US dollars.
Who is the portfolio manager of KPCB XV ASSOCIATES, LLC?
The portfolio manager of the KPCB XV ASSOCIATES, LLC is .
What is the total asset value of the KPCB XV ASSOCIATES, LLC portfolio?
KPCB XV ASSOCIATES, LLC total asset value (portfolio value) is 35.84M US dollars.
Who is ?
is the portfolio manager of the KPCB XV ASSOCIATES, LLC.
What is (KPCB XV ASSOCIATES, LLC) fund performance?
KPCB XV ASSOCIATES's quarterly performance is -5.12%, annualy -61.81%.
What is the KPCB XV ASSOCIATES, LLC CIK?
KPCB XV ASSOCIATES's Central Index Key is 0001547838 .